Skip to main content
. Author manuscript; available in PMC: 2007 Oct 17.
Published in final edited form as: J Neuroimmunol. 2006 Dec 13;183(1-2):189–199. doi: 10.1016/j.jneuroim.2006.10.020

Table 2.

OND Patient Summary1

CIS 132 OND 142 OND 341 OND 658 CIS 681 OND 758 OND 766
OND subcategory CIS NIND OIND OIND CIS3 NIND NIND
Age/Sex 24/F 32/F 70/M 30/F 53/F 45/F 33/F
Presentation or Diagnosis at time of sampling Diplopia2 HA Ataxia, PS Ataxia Neuroma HA HA
MRI Findings GD+ WML No Lesions No lesions WML WML WML
Clonal Expansion No No No n.d. No Yes No

Abbreviations: OND; Other Neurological Disease, CIS; Clinically Isolated Syndrome, NIND; non-inflammatory neurological disease, OIND; Other Inflammatory Neurological Disease, HA; Headache, PS; Paraneoplastic Syndrome, GD+; Gadolinium Enhancing, WML; White Matter Lesions

1

All patients had CSF white blood cell (WBC) counts typical of OND controls at UTSWMC (Stuve, Ann. Neurol., 2006)

2

This patient converted to clinically definite MS according to the Poser Criteria 18 months after sampling.

3

This patient’s CSF analysis was negative for oligoclonal bands, and normal for Ig synthesis and rate.